Published 2018 | Version v1
Publication

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Citation

An error occurred while generating the citation.

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023